Longpre Lara — SEC Form 4 filings

SEC reporting owner CIK 1780347. 4 Form 4 filings on record with FilingPulse; latest filed 2024-03-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-01-09 to 2024-03-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mirum Pharmaceuticals, Inc. (MIRM)CHIEF DEVELOPMENT OFFICER41 leg · 965 sh · $10,2683 legs · 2,869 sh · $71,4362

Form 4 filings — Longpre Lara

FiledFormIssuerReported transactionsSource
2024-03-184Mirum Pharmaceuticals, Inc. (MIRM)Purchase (P): 965 @ $10.64 · Sale (S): 1,003 @ $20.62EDGAR
2024-02-054Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 847 @ $26.19EDGAR
2024-01-254Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 32,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0EDGAR
2024-01-094Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 1,019 @ $28.04EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780347 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →